May 28, 2019
Biomunex Pharmaceuticals Establishes US Subsidiary
Biomunex Inc. to focus on R&D and business development activities in the US PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Biomunex Pharmaceuticals, a…
Pharmaceuticals, Biotechnology and Life Sciences
Biomunex Inc. to focus on R&D and business development activities in the US PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Biomunex Pharmaceuticals, a…
AUSTIN, Texas–(BUSINESS WIRE)–CherryCircle Software, the company providing the QbDVision® platform to accelerate the development of manufacturing processes for the pharmaceutical…
SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/ALS?src=hash" target="_blank"gt;#ALSlt;/agt;–Neuropore Therapies, Inc. announced today that partner UCB initiated a multicenter clinical trial in Parkinson’s disease…
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA™ (NYSE:IQV) today announced that three of the company’s women leaders have received…
– KVD900 Phase 1 Data Show Rapid Suppression of Plasma Kallikrein Activity and is Well Tolerated for Potential Use as…
TORONTO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/FSDDF?src=hash" target="_blank"gt;#FSDDFlt;/agt;–FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), today announced the appointment…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…
Enrollment of cohort 2 was completed six months ahead of schedule Cohort 2 had a target enrollment of 87 NSCLC…
Partnership accelerates access to inebilizumab in China and supports the mission of both companies to bring transformative therapies to more…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cadent Therapeutics, a company focused on the development of therapies to improve the lives of patients with movement…